Hurley Capital’s IGC Pharma IGC Stock Holding History

Hurley Capital’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26	Hold	100	–	–	﹤0.01%	658
2025 Q4	$28	Hold	100	–	–	﹤0.01%	586
2025 Q3	$42	Hold	100	–	–	﹤0.01%	684
2025 Q2	$31	Hold	100	–	–	﹤0.01%	459
2025 Q1	$29	Hold	100	–	–	﹤0.01%	495
2024 Q4	$36	Buy	+100	New	+$37	﹤0.01%	401

Other funds holding IGC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $148M AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hurley Capital's IGC Position: Q1 2026 in Review

Hurley Capital held its IGC Pharma (IGC) position steady in Q1 2026 at 100 shares worth $26. The position accounts for ﹤0.01% of the portfolio, ranked #658.

Hurley Capital first reported a position in IGC in Q4 2024 and has held it in 6 quarters since. The position peaked at $42 in Q3 2025. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

Hurley Capital held 100 shares of IGC Pharma worth $26 as of Q1 2026.
Hurley Capital left its IGC Pharma share count unchanged in Q1 2026.
IGC Pharma made up ﹤0.01% of Hurley Capital's portfolio in Q1 2026, its #658 holding.
Hurley Capital first reported a position in IGC Pharma in Q4 2024 and has held it in 6 quarters since.
Hurley Capital's IGC Pharma position peaked at $42 in Q3 2025.
35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.